Genesis facilities resolve allegations in connection with denying admission to opioid-dependent seniors
By
Alicia Lasek
Aug 09, 2021
Prospective residents were taking either buprenorphine or methadone for opioid use disorder. Twelve SNFs must pay civil penalties, adopt non-discrimination policy and provide training on civil rights laws...
Residents’ lack of energy may signal malnutrition; full assessment advised
By
Alicia Lasek
Aug 10, 2021
In a study of 13 nursing homes, fully 43% of residents reported that they lacked energy, and 12% were malnourished. The two problems were significantly linked, investigators say.
New CDC data: Vaccinated older adults have low chance of COVID hospitalization
By
Alicia Lasek
Aug 09, 2021
The three FDA-authorized COVID-19 vaccines are highly effective in keeping the oldest adults out of the hospital, according to federal data released Friday.
Show us the data: COVID vaccine boosters may get go-ahead, but LTC docs remain wary
By
Alicia Lasek
Danielle Brown
Aug 09, 2021
Booster shots for the most vulnerable appear to be on a fast track to federal authorization. But clinicians want information about necessity, safety, dosing and more to justify prescribing an extra dose...
All nursing home staff in Massachusetts must get COVID-19 shots
By
Alicia Lasek
Aug 05, 2021
The state is requiring staff and contract employees in all of its 378 facilities to receive a vaccination, Gov. Charlie Baker announced Wednesday.
Eli Lilly aims for dementia drug candidate’s approval in 2022; wants to ‘prioritize access’
By
Alicia Lasek
Aug 04, 2021
The Alzheimer’s disease-modifying drug donanemab is on track to be considered for full FDA approval by 2022, its developer said.
Long-term care facility docs vs. aides: CDC study finds wide vaccination gulf
By
Alicia Lasek
Aug 03, 2021
There is a 30% difference in COVID-19 vaccination coverage between LTC physicians and facility aides, CDC reports. And rates among aides are lowest in zip codes where vulnerability to poor health outcomes...
FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.
Shorter course of antibiotics effective in men with UTI, comparison shows
By
Alicia Lasek
Jul 30, 2021
A seven-day course of antibiotics is no less effective than a 14-day course for resolving urinary tract infections in men with no fever, a new study finds.
Clinical briefs for Friday, July 30
By
Alicia Lasek
Jul 30, 2021
AHCA / NCAL back mandatory COVID-19 vaccinations for healthcare workers … Vaccinated but exposed to virus? Get tested, CDC now recommends … Aduhelm’s developer begins a real-world study of controversial...